| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/09/2005 | EP1504757A2 Controlled-release formulations coated with aqueous dispersions of ethylcellulose |
| 02/09/2005 | EP1504756A1 Medicament compositions comprising a heterocyclic compound and an anticholinergic |
| 02/09/2005 | EP1504755A1 Lyophilization product |
| 02/09/2005 | EP1504744A1 Aerosol cosmetic composition |
| 02/09/2005 | EP1504673A1 Hard sugar coated preparations, sugar coating solutions and process for producing hard sugar coated preparation |
| 02/09/2005 | EP1504055A1 Modified polymeric films |
| 02/09/2005 | EP1504047A1 Polymeric microemulsions |
| 02/09/2005 | EP1504040A1 Method for reduction of residual organic solvent in carbomer |
| 02/09/2005 | EP1503805A1 Lyophilized edible food incorporating a marker |
| 02/09/2005 | EP1503803A1 Medicinal formulation in particular for treating herniated invertebral discs |
| 02/09/2005 | EP1503801A2 Non-invasive delivery of polypeptides through the blood-brain barrier, and in vivo selection of endocytotic ligands |
| 02/09/2005 | EP1503797A1 Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activity |
| 02/09/2005 | EP1503796A1 Compositions and methods for delivery of photosensitive drugs |
| 02/09/2005 | EP1503789A2 Vascularization enhanced graft constructs |
| 02/09/2005 | EP1503781A1 Treatment for weight loss |
| 02/09/2005 | EP1503772A1 Soluble composition containing sporopollenin and the use thereof |
| 02/09/2005 | EP1503769A1 Antibiotic/benzoyl peroxide dispenser |
| 02/09/2005 | EP1503766A2 Compositions and methods for treating emphysema |
| 02/09/2005 | EP1503763A1 Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith |
| 02/09/2005 | EP1503753A2 A method for inhibiting platelet aggregation |
| 02/09/2005 | EP1503747A1 Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders |
| 02/09/2005 | EP1503744A1 Delivery of drug amines through an inhalation route |
| 02/09/2005 | EP1503743A1 Transdermal delivery system with two superimposed adhesive layers having different affinities to the active substance comprised |
| 02/09/2005 | EP1503742A2 Matrix comprising a bioactive component containing phospholipid |
| 02/09/2005 | EP1503741A2 Diffusion-controlled dosage form and method of fabrication including three dimensional printing |
| 02/09/2005 | EP1503740A1 Monocompartment osmotic controlled drug delivery system |
| 02/09/2005 | EP1503739A1 Sustained release of guaifenesin combination drugs |
| 02/09/2005 | EP1503738A1 Use of completely linear short chain alpha-glucans as a pharmaceutical excipient |
| 02/09/2005 | EP1503737A1 Nanoparticulate nystatin formulations |
| 02/09/2005 | EP1503736A1 Air treatment gel and method for its preparation |
| 02/09/2005 | EP1503735A2 A direct cellular energy delivery system |
| 02/09/2005 | EP1503734A2 Methods and apparatus for modifying properties of the bbb and cerebral circulation by using the neuroexcitatory and/or neuroinhibitory effects of odorants on nerves in the head |
| 02/09/2005 | EP1503733A1 Oleaginous oral antiparasitic compositions |
| 02/09/2005 | EP1503732A2 Reduced formate poly(alkylene oxides) with secondary amines for reducing impurity formation |
| 02/09/2005 | EP1503731A1 Processes for forming a drug delivery device |
| 02/09/2005 | EP1503730A2 Growth factor delivery system for the healing of wounds and the prevention of inflammation and disease |
| 02/09/2005 | EP1503722A2 Cosmetic product comprising at least one water-soluble copolymer which contains (meth)acrylamide units |
| 02/09/2005 | EP1503640A2 Make-up applicator with led light source |
| 02/09/2005 | EP1461101A4 Metering valve and pharmaceutical metered dose inhaler and methods thereof |
| 02/09/2005 | EP1453816A4 Phenoxy amine compounds and compositions for delivering active agents |
| 02/09/2005 | EP1420802A4 Increased solubility flavanolignan preparations |
| 02/09/2005 | EP1390031B1 Topical composition containing a fungicide |
| 02/09/2005 | EP1370268A4 Methods for treating stress disorders using glucocorticoid receptor-specific antagonists |
| 02/09/2005 | EP1284601A4 Allantoin-containing skin cream |
| 02/09/2005 | EP1242121B1 Polypeptide compositions with improved stability |
| 02/09/2005 | EP1242112A4 Particulate drug-containing products and method of manufacture |
| 02/09/2005 | EP1210119B1 Pharmaceutical compositions for oral and topical administration |
| 02/09/2005 | EP1191924A4 Pharmaceutical dosage form for pulsatile delivery of (d-threo)-methylphenidate and a second cns stimulant |
| 02/09/2005 | EP1165054A4 Pharmaceutical dosage form for pulsatile delivery of methylphenidate |
| 02/09/2005 | EP1150960B1 Polymorphic crystalline forms of celecoxib |
| 02/09/2005 | EP1124443B1 Solid delivery systems for aroma ingredients |
| 02/09/2005 | EP1096919B1 Endoscopic transluminal delivery device comprising a pellet containing a local anesthetic agent |
| 02/09/2005 | EP1079813B1 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 02/09/2005 | EP1027015B1 Controlled release of pharmaceuticals in the anterior chamber of the eye |
| 02/09/2005 | EP1023440B1 Enteric coated microgranules for stabilizing lactic acid bacteria |
| 02/09/2005 | EP0971705B1 Hormone replacement therapy drug formulations for topical application to the skin |
| 02/09/2005 | EP0957927B1 Medical composition and use thereof for the manufacture of a topical barrier formulation, a uv-radiation absorbing formulation, or an antiviral, antifungal, or antiinflammatory formulation |
| 02/09/2005 | CN2676917Y 壳聚糖药膜 Chitosan film with |
| 02/09/2005 | CN1578724A System, method and apparatus for producing dosage forms |
| 02/09/2005 | CN1578681A Plaster having laminated support |
| 02/09/2005 | CN1578677A Improved therapeutic protocols |
| 02/09/2005 | CN1578676A Lox concentration of peroxide for treating or preventing vaginal infections |
| 02/09/2005 | CN1578675A Extended, controlled-release pharmaceutical compositions using charged polymers |
| 02/09/2005 | CN1578672A Rsv基因表达疫苗 Rsv gene expression vaccine |
| 02/09/2005 | CN1578670A Use of lactalapoprotein in prevention and treatment of microbial or virus infection |
| 02/09/2005 | CN1578664A Depot formulations of iloperidone and a star polymer |
| 02/09/2005 | CN1578657A Process for the preparation of fast dissolving dosage form |
| 02/09/2005 | CN1578650A Compositions for the treatment of infectious diseases |
| 02/09/2005 | CN1578647A Implantable and sealable system for unidirectional delivery of therapeutic agents to tissues |
| 02/09/2005 | CN1578626A Multivesicular emulsion topical delivery systems |
| 02/09/2005 | CN1578624A Non-toxic crosslinking reagents to resist curve progression in scoliosis and increase disc permeability |
| 02/09/2005 | CN1575848A Emulsifier for highly liquid w/o emulsion |
| 02/09/2005 | CN1575819A Use of melanoma differentiation associated gene (mda-7) for reversing cancerous phenotype |
| 02/09/2005 | CN1575817A Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same |
| 02/09/2005 | CN1575805A Scarless wound healing ointment |
| 02/09/2005 | CN1575798A Rapid disintegration and rapid dissolution tablet containing kakonein |
| 02/09/2005 | CN1575796A Ligustrazine phosphate dripping pill and preparation thereof |
| 02/09/2005 | CN1575795A Naloxone hydrochloride nasal spray |
| 02/09/2005 | CN1575794A Liquid prepartion containing rosickyite imidazole sulfoxide |
| 02/09/2005 | CN1575793A Functional chewing gum composition for improving effectively obesity and blood fat |
| 02/09/2005 | CN1575792A Method for stablizing protein medicine and its application in microball preparation |
| 02/09/2005 | CN1188704C Method For releasing medicament, all composition therein, its use and reagent box |
| 02/09/2005 | CN1188189C Transdermal patch substrate containing 17-deacetyl norgestimate and use of substrate |
| 02/09/2005 | CN1188176C Coating useful as dispenser of active ingredient no dressings and bandages |
| 02/09/2005 | CN1188171C Method of preventing aggregation of various substances upon rehydration or thawing and compositions obtained thereby |
| 02/09/2005 | CN1188170C Solution comprising prostaglandins and benzyl alcohol |
| 02/09/2005 | CN1188164C Compositions and method for regulating phagocytosis and ICAM-1 expression |
| 02/09/2005 | CN1188163C Medicine for curing cough due to exopathy for children and preparation method thereof |
| 02/09/2005 | CN1188151C Analgesic injection |
| 02/09/2005 | CN1188136C Buffered composition for dialysis |
| 02/09/2005 | CN1188134C Preparation having increased in vivo tolerability |
| 02/09/2005 | CN1188131C Orally taken pulsed releasing system of phenyl diazepine medicine and its prepn |
| 02/09/2005 | CN1188130C Quetiapine granules |
| 02/09/2005 | CN1188126C Preparation of compound Famotine dispersant pills |
| 02/09/2005 | CN1188124C Process for preparing ginkgolide injection |
| 02/09/2005 | CN1188122C 新制剂 The new formulation |
| 02/09/2005 | CN1188116C Ointment applicator and ointment patch employing the same |
| 02/09/2005 | CN1188115C Selectively-activatible sheet material for dispensing and dispersing a substance onto a target surface |
| 02/09/2005 | CN1188114C 可食包衣组合物 Edible coating composition |
| 02/09/2005 | CN1188113C Pharmaceutical mixture comprising a combination of a profen and other active compounds |